The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 538-546

  Kumar, Amrita ^a   Wu, Huixia ^a   Collier Hyams, Lauren S ^a   Kwon, Young Man ^a   Hanson, Jason M ^a   Neish, Andrew S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CULLIN; CULLIN 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 12; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; I KAPPA B; NEDD8 PROTEIN, HUMAN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ACTIVATION; EPITHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; INTESTINE FLORA; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BACTERIUM; CELL CULTURE; CELL STRAIN CACO 2; CELL STRAIN HL 60; COLON; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FERMENTATION; HELA CELL; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; UBIQUITINATION;

BACTERIA; BUTYRATES; CACO-2 CELLS; CELLS, CULTURED; COLON; CULLIN PROTEINS; FERMENTATION; HELA CELLS; HL-60 CELLS; HUMANS; I-KAPPA B PROTEINS; INTESTINAL MUCOSA; NF-KAPPA B; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; UBIQUITINATION; UBIQUITINS;

EID: 59849113820     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.538     Document Type: Article

References (76)

1. Falk, P. G., L. V. Hooper, T. Midtvedt, and J. I. Gordon. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62: 1157-1170.
2. Hooper, L. V., M. H. Wong, A. Thelin, L. Hansson, P. G. Falk, and J. I. Gordon. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884.
3. Hooper, L. V., and J. I. Gordon. 2001. Commensal host-bacterial relationships in the gut. Science 292: 1115-1118.
4. Hooper, L. V., T. Midtvedt, and J. I. Gordon. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22: 283-307.
5. Topping, D. L., and P. M. Clifton. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81: 1031-1064.
6. Hamer, H. M., D. Jonkers, K. Venema, S. Vanhoutvin, F. J. Troost, and R. J. Brummer. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol. Ther. 27: 104-119.
7. Wong, J. M., R. de Souza, C. W. Kendall, A. Emam, and D. J. Jenkins. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40: 235-243.
8. Wachtershauser, A., and J. Stein. 2000. Rationale for the luminal provision of butyrate in intestinal diseases. Eur. J. Nutr. 39: 164-171.
9. Vernia, P., V. Annese, G. Bresci, G. d'Albasio, R. D'Inca, S. Giaccari, M. Ingrosso, C. Mansi, G. Riegler, D. Valpiani, and R. Caprilli. 2003. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur. J. Clin. Invest. 33: 244-248.
10. Winston, J. T., P. Strack, P. Beer-Romero, C. Y. Chu, S. J. Elledge, and J. W. Harper. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13: 270-283.
11. Spencer, E., J. Jiang, and Z. J. Chen. 1999. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev. 13: 284-294.
12. Pan, Z. Q., A. Kentsis, D. C. Dias, K. Yamoah, and K. Wu. 2004. Nedd8 on Cullin: building an expressway to protein destruction. Oncogene 23: 1985-1997.
13. Liakopoulos, D., G. Doenges, K. Matuschewski, and S. Jentsch. 1998. A novel protein modification pathway related to the ubiquitin system. EMBO J. 17: 2208-2214.
14. Kamitani, T., K. Kito, H. P. Nguyen, and E. T. Yeh. 1997. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 272: 28557-28562.
15. Parry, G., and M. Estelle. 2004. Regulation of cullin-based ubiquitin ligases by the Nedd8/RUB ubiquitin-like proteins. Semin. Cell Dev. Biol. 15: 221-229.
16. Ohh, M., W. Y. Kim, J. J. Moslehi, Y. Chen, V. Chau, M. A. Read, and W. G. Kaelin, Jr. 2002. An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep. 3: 177-182.
17. β(TrCP)-dependent ubiquitination of IκBα. Mol. Cell. Biol. 20: 2326-2333.
18. Furukawa, M., Y. Zhang, J. McCarville, T. Ohta, and Y. Xiong. 2000. The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1. Mol. Cell. Biol. 20: 8185-8197.
19. β-TrCP-mediated ubiquitination and processing of the NF-κB precursor p105. J. Biol. Chem. 277: 23253-23259.
20. β-TrCP ubiquitin ligase. Oncogene 23: 2540-2547.
21. Collier-Hyams, L. S., V. Sloane, B. C. Batten, and A. S. Neish. 2005. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J. Immunol. 175: 4194-4198.
22. Kumar, A., H. Wu, L. S. Collier-Hyams, J. M. Hansen, T. Li, K. Yamoah, Z. Q. Pan, D. P. Jones, and A. S. Neish. 2007. Commensal bacteria modulate Cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26: 4457-4466.
23. + T cells in vivo. J. Immunol. 169: 3914-3919.
24. Zeng, H., A. Q. Carlson, Y. Guo, Y. Yu, L. S. Collier-Hyams, J. L. Madara, A. T. Gewirtz, and A. S. Neish. 2003. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J. Immunol. 171: 3668-3674.
25. Wang, H., and J. A. Joseph. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol. Med. 27: 612-616.
26. Halvey, P. J., W. H. Watson, J. M. Hansen, Y. M. Go, A. Samali, and D. P. Jones. 2005. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem. J. 386: 215-219.
27. Watson, W. H., and D. P. Jones. 2003. Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett. 543: 144-147.
28. Segain, J. P., D. Raingeard de la Bletiere, A. Bourreille, V. Leray, N. Gervois, C. Rosales, L. Ferrier, C. Bonnet, H. M. Blottiere, and J. P. Galmiche. 2000. Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47: 397-403.
29. Yin, L., G. Laevsky, and C. Giardina. 2001. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J. Biol. Chem. 276: 44641-44646.
30. Nugent, S. G., D. Kumar, D. S. Rampton, and D. F. Evans. 2001. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut 48: 571-577.
31. Weng, M., W. A. Walker, and I. R. Sanderson. 2007. Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr. Res. 62: 542-546.
32. Collier-Hyams, L. S., and A. S. Neish. 2005. Innate immune relationship between commensal flora and the mammalian intestinal epithelium. Cell Mol. Life Sci. 62: 1339-1348.
33. Neish, A. S., A. T. Gewirtz, H. Zeng, A. N. Young, M. E. Hobert, V. Karmali, A. S. Rao, and J. L. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289: 1560-1563.
34. Wada, H., E. T. Yeh, and T. Kamitani. 2000. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J. Biol. Chem. 275: 17008-17015.
35. Cardozo, T., and M. Pagano. 2004. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol. 5: 739-751.
36. Lyapina, S., G. Cope, A. Shevchenko, G. Serino, T. Tsuge, C. Zhou, D. A. Wolf, N. Wei, and R. J. Deshaies. 2001. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292: 1382-1385.
37. Bostick, M., S. R. Lochhead, A. Honda, S. Palmer, and J. Callis. 2004. Related to ubiquitin 1 and 2 are redundant and essential and regulate vegetative growth, auxin signaling, and ethylene production in Arabidopsis. Plant Cell 16: 2418-2432.
38. Kurz, T., L. Pintard, J. H. Willis, D. R. Hamill, P. Gonczy, M. Peter, and B. Bowerman. 2002. Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification pathway. Science 295: 1294-1298.
39. Ou, C. Y., Y. F. Lin, Y. J. Chen, and C. T. Chien. 2002. Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development. Genes Dev. 16: 2403-2414.
40. Tateishi, K., M. Omata, K. Tanaka, and T. Chiba. 2001. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J. Cell Biol. 155: 571-579.
41. Cope, G. A., and R. J. Deshaies. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114: 663-671.
42. Groisman, R., J. Polanowska, I. Kuraoka, J. Sawada, M. Saijo, R. Drapkin, A. F. Kisselev, K. Tanaka, and Y. Nakatani. 2003. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113: 357-367.
43. Wang, X., S. Feng, N. Nakayama, W. L. Crosby, V. Irish, X. W. Deng, and N. Wei. 2003. The COP9 signalosome interacts with SCF UFO and participates in Arabidopsis flower development. Plant Cell 15: 1071-1082.
44. Khoury, J., J. C. Ibla, A. S. Neish, and S. P. Colgan. 2007. Antiinflammatory adaptation to hypoxia through adenosine-mediated Cullin-1 deneddylation. J. Clin. Invest. 117: 703-711.
45. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661.
46. Mahadev, K., X. Wu, A. Zilbering, L. Zhu, J. T. Lawrence, and B. J. Goldstein. 2001. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 276: 48662-48669.
47. Mahadev, K., A. Zilbering, L. Zhu, and B. J. Goldstein. 2001. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276: 21938-21942.
48. Chen, K. C., Y. Zhou, K. Xing, K. Krysan, and M. F. Lou. 2004. Platelet derived growth factor (PDGF)-induced reactive oxygen species in the lens epithelial cells: the redox signaling. Exp. Eye Res. 78: 1057-1067.
49. Goldstein, B. J., K. Mahadev, X. Wu, L. Zhu, and H. Motoshima. 2005. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal 7: 1021-1031.
50. Lambeth, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4: 181-189.
51. Terada, L. S. 2006. Specificity in reactive oxidant signaling: think globally, act locally. J. Cell Biol. 174: 615-623.
52. Tonks, N. K. 2005. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121: 667-670.
53. Chiarugi, P., and F. Buricchi. 2007. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid. Redox Signal 9: 1-24.
54. Seo, J. H., Y. Ahn, S. R. Lee, C. Yeol Yeo, and K. Chung Hur. 2005. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell 16: 348-357.
55. Veal, E. A., A. M. Day, and B. A. Morgan. 2007. Hydrogen peroxide sensing and signaling. Mol. Cell 26: 1-14.
56. Bossis, G., and F. Melchior. 2006. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21: 349-357.
57. Apel, K., and H. Hirt. 2004. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 55: 373-399.
58. Jeng, J. H., M. Y. Kuo, P. H. Lee, Y. J. Wang, M. Y. Lee, J. J. Lee, B. R. Lin, T. F. Tai, and M. C. Chang. 2006. Toxic and metabolic effect of sodium butyrate on SAS tongue cancer cells: role of cell cycle deregulation and redox changes. Toxicology 223: 235-247.
59. Hsiao, C. H., W. Li, T. F. Lou, B. S. Baliga, and B. S. Pace. 2006. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. Exp. Hematol. 34: 264-273.
60. Velazquez, O. C., H. M. Lederer, and J. L. Rombeau. 1997. Butyrate and the colonocyte: production, absorption, metabolism, and therapeutic implications. Adv. Exp. Med. Biol. 427: 123-134.
61. Stein, J., M. Zores, and O. Schroder. 2000. Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism. Eur. J. Nutr. 39: 121-125.
62. Charney, A. N., L. Micic, and R. W. Egnor. 1998. Nonionic diffusion of short-chain fatty acids across rat colon. Am. J. Physiol. 274: G518-G524.
63. Cotran, R., V. Kumar, and T. Collins. 1999. The Pathologic Basis of Disease. Saunders, Philadelphia.
64. Clark, D. A., J. E. Thompson, L. B. Weiner, J. A. McMillan, A. J. Schneider, and J. E. Rokahr. 1985. Necrotizing enterocolitis: intraluminal biochemistry in human neonates and a rabbit model. Pediatr. Res. 19: 919-921.
65. Sanderson, I. R. 1999. The physicochemical environment of the neonatal intestine. Am. J. Clin. Nutr. 69: 1028S-1034S.
66. Nafday, S. M., W. Chen, L. Peng, M. W. Babyatsky, I. R. Holzman, and J. Lin. 2005. Short-chain fatty acids induce colonic mucosal injury in rats with various postnatal ages. Pediatr. Res. 57: 201-204.
67. McCafferty, D. M., and I. J. Zeitlin. 1989. Short chain fatty acid-induced colitis in mice. Int. J. Tissue React. 11: 165-168.
68. Teitelbaum, J. E., and W. A. Walker. 2002. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22: 107-138.
69. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
70. Klein, G., A. Pack, C. Bonaparte, and G. Reuter. 1998. Taxonomy and physiology of probiotic lactic acid bacteria. Int. J. Food Microbiol. 41: 103-125.
71. Flint, H. J., S. H. Duncan, K. P. Scott, and P. Louis. 2007. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ. Microbiol. 9: 1101-1111.
72. Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114.
73. Pena, J. A., and J. Versalovic. 2003. Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol. 5: 277-285.
74. Menard, S., C. Candalh, J. C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman. 2004. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53: 821-828.
75. Scheppach, W., and F. Weiler. 2004. The butyrate story: old wine in new bottles? Curr. Opin. Clin. Nutr. Metab. Care 7: 563-567.
76. McFall-Ngai, M. J. 2002. Unseen forces: the influence of bacteria on animal development. Dev. Biol. 242: 1-14.